Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
AND
Fourth Extension - Granted
Show more
Class 1: Biological and chemical agents for scientific use other than for medical use, namely, addressable and programmable protein-based therapeutics
Class 5: Biological therapeutics, namely, addressable and programmable protein-based therapeutics, including multi-specific polypeptide-based therapeutics, namely, therapeutic pharmaceuticals for the treatment of genetic diseases and disorders, genomic diseases and disorders, hematological disorders, hormonal disorders, infectious diseases, reproductive disorders, metabolic disorders, orthopedic conditions, musculoskeletal diseases and disorders, gastrointestinal diseases and disorders, immune system-related diseases and disorders, dermatological diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, cancer, diabetes, and respiratory diseases and disorders…
Class 42: Drug development services, namely, pharmaceutical drug development services; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products, namely, pharmaceutical drug development services; pharmaceutical and biotech research and development, namely, pharmaceutical drug development services
Class 1 – ChemicalsClass 5 – Pharmaceuticals & supplementsClass 42 – Technology & SaaS
Status timeline
- 26 May 2023Assigned to an examining attorneyAssigned To Examiner
- 27 May 2023Office action issuedNon-Final Action Written
- 22 Aug 2023Response to office action filedTeas Response To Office Action Received
- 23 Aug 2023Ownership assignment recordedAutomatic Update Of Assignment Of Ownership
- 24 Oct 2023Final refusal issuedFinal Refusal Mailed
- 20 Jan 2024Approved for publicationApproved For Pub - Principal Register
- 27 Feb 2024Published for oppositionPublished For Opposition
- 23 Apr 2024Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 18 Oct 2024Statement-of-use extension 1 grantedSou Extension 1 Granted
- 12 Mar 2025Statement-of-use extension 2 grantedSou Extension 2 Granted
- 22 Oct 2025Statement-of-use extension 3 grantedSou Extension 3 Granted
All 44 events
| 2026-02-27 | Notice Of Approval Of Extension Request E-Mailed |
| 2026-02-26 | Sou Teas Extension Received |
| 2026-02-26 | Sou Extension 4 Filed |
| 2026-02-26 | Sou Extension 4 Granted |
| 2025-10-23 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-10-22 | Sou Teas Extension Received |
| 2025-10-22 | Sou Extension 3 Filed |
| 2025-10-22 | Sou Extension 3 Granted |
| 2025-03-13 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-03-12 | Sou Teas Extension Received |
| 2025-03-12 | Sou Extension 2 Filed |
| 2025-03-12 | Sou Extension 2 Granted |
| 2025-01-07 | Teas Change Of Owner Address Received |
| 2025-01-07 | Applicant/Correspondence Changes (Non-Responsive) Entered |
| 2025-01-07 | Teas Change Of Correspondence Received |
| 2024-10-18 | Sou Teas Extension Received |
| 2024-10-18 | Sou Extension 1 Filed |
| 2024-10-18 | Sou Extension 1 Granted |
| 2024-10-18 | Notice Of Approval Of Extension Request E-Mailed |
| 2024-04-23 | Noa Mailed - Sou Required From Applicant |
| 2024-03-04 | Official Gazette Publication Confirmation E-Mailed |
| 2024-02-27 | Published For Opposition |
| 2024-02-07 | Notification Of Notice Of Publication E-Mailed |
| 2024-02-07 | Official Gazette Publication Confirmation E-Mailed |
| 2024-01-20 | Approved For Pub - Principal Register |
| 2024-01-19 | Teas/Email Correspondence Entered |
| 2024-01-18 | Teas Change Of Owner Address Received |
| 2024-01-18 | Applicant/Correspondence Changes (Non-Responsive) Entered |
| 2024-01-18 | Teas Change Of Correspondence Received |
| 2024-01-18 | Teas Request For Reconsideration Received |
| 2024-01-18 | Correspondence Received In Law Office |
| 2023-10-24 | Final Refusal Mailed |
| 2023-10-24 | Final Refusal E-Mailed |
| 2023-10-24 | Notification Of Final Refusal Emailed |
| 2023-10-04 | Assignment Of Ownership Not Updated Automatically |
| 2023-08-23 | Automatic Update Of Assignment Of Ownership |
| 2023-08-22 | Teas Response To Office Action Received |
| 2023-08-22 | Correspondence Received In Law Office |
| 2023-08-22 | Teas/Email Correspondence Entered |
| 2023-05-27 | Non-Final Action Written |
| 2023-05-27 | Non-Final Action E-Mailed |
| 2023-05-27 | Notification Of Non-Final Action E-Mailed |
| 2023-05-26 | Assigned To Examiner |
| 2022-11-08 | New Application Office Supplied Data Entered |
Goods & services by class
Class 1 Chemicals
Biological and chemical agents for scientific use other than for medical use, namely, addressable and programmable protein-based therapeutics
Class 5 Pharmaceuticals & supplements
Biological therapeutics, namely, addressable and programmable protein-based therapeutics, including multi-specific polypeptide-based therapeutics, namely, therapeutic pharmaceuticals for the treatment of genetic diseases and disorders, genomic diseases and disorders, hematological disorders, hormonal disorders, infectious diseases, reproductive disorders, metabolic disorders, orthopedic conditions, musculoskeletal diseases and disorders, gastrointestinal diseases and disorders, immune system-related diseases and disorders, dermatological diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, cancer, diabetes, and respiratory diseases and disorders…
Class 42 Technology & SaaS
Drug development services, namely, pharmaceutical drug development services; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products, namely, pharmaceutical drug development services; pharmaceutical and biotech research and development, namely, pharmaceutical drug development services
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 28 Feb 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.